Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) recorded quarterly Amortizatization of Intangibles of $6.3 million in Q1 2026, up 151.09% quarter-over-quarter from -$12.3 million in Q4 2025, and little changed on a YoY basis from $6.2 million in Q1 2025.
Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.48% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $6.5 million (down 73.64% YoY), while the FY2025 annual figure was $6.5 million, down 73.68% from the prior year.
- Amortizatization of Intangibles was $6.3 million for Q1 2026 at Amphastar Pharmaceuticals, up from -$12.3 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $15.6 million in Q3 2025 to a low of -$12.3 million in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $2.6 million across 5 years, with a median of $2.1 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles slumped 422.51% in 2023, then jumped 2592.61% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $902000.0 in 2022, then plunged by 422.51% to -$2.9 million in 2023, then jumped by 312.41% to $6.2 million in 2024, then sank by 298.61% to -$12.3 million in 2025, then jumped by 151.09% to $6.3 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $6.3 million (Q1 2026), -$12.3 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Amphastar Pharmaceuticals | 918.00 Mn | 918.00 Mn | 70.32 Mn | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.27 Mn |
| Mar 31, 2026 | 6.27 Mn |
| Dec 31, 2025 | -12.27 Mn |
| Dec 31, 2025 | -12.27 Mn |
| Sep 30, 2025 | 15.56 Mn |
| Sep 30, 2025 | 15.56 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | 6.17 Mn |
| Mar 31, 2024 | 6.17 Mn |
| Dec 31, 2023 | -2.91 Mn |
| Dec 31, 2023 | -2.91 Mn |